The results indicated that Kirenol has the potential to inhibit metastasis, as shown by its ability to reduce the migratory capacity of ovarian cancer cells and decrease the expression of key factors involved in cell migration and invasion, including MMP-2 and MMP-9. This evidence concerns the gene MMP2 and ovarian carcinoma.